US consumer group criticises FDA's "weak" device approval process
This article was originally published in SRA
Executive Summary
The quality of the US Food and Drug Administration's device approval process has been called into question by consumer advocacy group, Public Citizen, which claims that the agency's "lax" approach is allowing potentially ineffective devices onto the market.